HC Wainwright Reaffirms “Buy” Rating for Solid Biosciences (NASDAQ:SLDB)
HC Wainwright restated their buy rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. HC Wainwright currently has a $20.00 price objective on the stock. A number of other equities research analysts have also recently commented on SLDB. JPMorgan Chase & Co. reduced their […]
HC Wainwright restated their buy rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. HC Wainwright currently has a $20.00 price objective on the stock. A number of other equities research analysts have also recently commented on SLDB. JPMorgan Chase & Co. reduced their […]
